MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 52 filers reported holding MEI PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $12 | -99.7% | 52 | -99.7% | 0.00% | – |
| Q4 2022 | $3,713 | -95.7% | 15,244 | -93.3% | 0.00% | – |
| Q3 2022 | $87,000 | -26.3% | 226,142 | +16.0% | 0.00% | – |
| Q2 2022 | $118,000 | +686.7% | 195,028 | +3494.3% | 0.00% | – |
| Q3 2021 | $15,000 | -6.2% | 5,426 | -30.2% | 0.00% | – |
| Q4 2017 | $16,000 | +6.7% | 7,772 | +43.4% | 0.00% | – |
| Q3 2017 | $15,000 | -95.5% | 5,420 | -97.2% | 0.00% | -100.0% |
| Q2 2015 | $332,000 | -20.0% | 193,860 | -16.4% | 0.01% | -28.6% |
| Q1 2015 | $415,000 | +2493.8% | 231,871 | +6013.1% | 0.01% | – |
| Q4 2014 | $16,000 | +433.3% | 3,793 | +908.8% | 0.00% | – |
| Q3 2014 | $3,000 | -50.0% | 376 | -61.5% | 0.00% | – |
| Q2 2014 | $6,000 | -75.0% | 976 | -55.1% | 0.00% | – |
| Q1 2014 | $24,000 | -55.6% | 2,176 | -67.6% | 0.00% | -100.0% |
| Q4 2013 | $54,000 | -43.8% | 6,722 | -20.8% | 0.00% | -50.0% |
| Q3 2013 | $96,000 | – | 8,485 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |